{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T17:39:31Z","timestamp":1789925971357,"version":"4.0.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care: Clinics in Office Practice"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.pop.2020.08.003","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T07:29:53Z","timestamp":1601018993000},"page":"615-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Nephritic Syndrome"],"prefix":"10.1016","volume":"47","author":[{"given":"Perola","family":"Lamba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Heon","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigar","family":"Contractor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aram","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pop.2020.08.003_bib1","series-title":"Chronic kidney disease in the United States, 2019","year":"2019"},{"key":"10.1016\/j.pop.2020.08.003_bib2","series-title":"Robbins & Cotran pathologic basis of disease (Robbins Pathology)","first-page":"1408","author":"Kumar","year":"2015"},{"issue":"2","key":"10.1016\/j.pop.2020.08.003_bib3","first-page":"200","article-title":"Chapter 9: Infection-related glomerulonephritis","volume":"2","year":"2011","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.pop.2020.08.003_bib4","series-title":"Harrison\u2019s principles of internal medicine","year":"2012"},{"key":"10.1016\/j.pop.2020.08.003_bib5","series-title":"Pocket guide to Brenner and Rector\u2019s the kidney","first-page":"222","article-title":"Primary glomerular diseases","year":"2011"},{"issue":"1","key":"10.1016\/j.pop.2020.08.003_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.pcl.2018.08.005","article-title":"Infection-related glomerulonephritis","volume":"66","author":"Hunt","year":"2019","journal-title":"Pediatr Clin North Am"},{"issue":"10","key":"10.1016\/j.pop.2020.08.003_bib7","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1681\/ASN.2008010092","article-title":"The current state of poststreptococcal glomerulonephritis","volume":"19","author":"Rodriguez-Iturbe","year":"2008","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.pop.2020.08.003_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41581-019-0178-8","article-title":"Epidemiology, pathogenesis, treatment and outcomes of infection-associated glomerulonephritis","volume":"16","author":"Satoskar","year":"2020","journal-title":"Nat Rev Nephrol"},{"issue":"5","key":"10.1016\/j.pop.2020.08.003_bib9","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ki.2012.407","article-title":"Bacterial infection-related glomerulonephritis in adults","volume":"83","author":"Nasr","year":"2013","journal-title":"Kidney Int"},{"issue":"15","key":"10.1016\/j.pop.2020.08.003_bib10","doi-asserted-by":"crossref","first-page":"e3386","DOI":"10.1097\/MD.0000000000003386","article-title":"Clinical, pathological, and prognostic characteristics of glomerulonephritis related to staphylococcal infection","volume":"95","author":"Wang","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.pop.2020.08.003_bib11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2215\/CJN.07420716","article-title":"IgA Nephropathy","volume":"12","author":"Rodrigues","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"issue":"25","key":"10.1016\/j.pop.2020.08.003_bib12","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.pop.2020.08.003_bib13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/ki.2009.243","article-title":"The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification","volume":"76","author":"Cattran","year":"2009","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.pop.2020.08.003_bib14","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/ki.2009.168","article-title":"The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility","volume":"76","author":"Roberts","year":"2009","journal-title":"Kidney Int"},{"key":"10.1016\/j.pop.2020.08.003_bib15","series-title":"Brenner & rector\u2019s the kidney [electronic resource]","first-page":"1007","article-title":"Primary glomerular disease","author":"Saha","year":"2020"},{"issue":"6","key":"10.1016\/j.pop.2020.08.003_bib16","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ki.1991.313","article-title":"Deterioration of GFR in IgA nephropathy as measured by 51Cr-EDTA clearance","volume":"40","author":"Rekola","year":"1991","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.pop.2020.08.003_bib17","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1681\/ASN.2010040355","article-title":"Predicting the risk for dialysis or death in IgA nephropathy","volume":"22","author":"Berthoux","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.pop.2020.08.003_bib18","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/ajkd.2001.27689","article-title":"Predicting progression in IgA nephropathy","volume":"38","author":"Bartosik","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.pop.2020.08.003_bib19","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1681\/ASN.2013010026","article-title":"The pathogenesis of lupus nephritis","volume":"24","author":"Lech","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.pop.2020.08.003_bib20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/MAJ.0b013e3181907b3d","article-title":"Lupus nephritis","volume":"337","author":"Singh","year":"2009","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.pop.2020.08.003_bib21","series-title":"Glomerulonephritis","article-title":"Lupus nephritis (including antiphospholipid antibody syndrome), adult","author":"Anvari","year":"2019"},{"issue":"5","key":"10.1016\/j.pop.2020.08.003_bib22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.05780616","article-title":"Update on lupus nephritis","volume":"12","author":"Almaani","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.pop.2020.08.003_bib23","series-title":"Brenner & rector\u2019s the kidney [electronic resource]","first-page":"1092","article-title":"Secondary glomerular disease","author":"Radhakrishnan","year":"2020"},{"issue":"6","key":"10.1016\/j.pop.2020.08.003_bib24","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/acr.21664","article-title":"American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis","volume":"64","author":"Hahn","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"11","key":"10.1016\/j.pop.2020.08.003_bib25","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/annrheumdis-2012-201940","article-title":"Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis","volume":"71","author":"Bertsias","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.pop.2020.08.003_bib26","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1681\/ASN.2010050472","article-title":"Updates on the treatment of lupus nephritis","volume":"21","author":"Bomback","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.pop.2020.08.003_bib27","first-page":"1563","article-title":"Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure","volume":"33","author":"Faurschou","year":"2006","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.pop.2020.08.003_bib28","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0002-9343(87)90645-0","article-title":"Long-term follow-up of patients with lupus nephritis. A study based on the classification of the World Health Organization","volume":"83","author":"Appel","year":"1987","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.pop.2020.08.003_bib29","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0272-6386(00)70262-9","article-title":"Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group","volume":"35","author":"Korbet","year":"2000","journal-title":"Am J Kidney Dis"},{"issue":"20","key":"10.1016\/j.pop.2020.08.003_bib30","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1056\/NEJMoa1014460","article-title":"Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis","volume":"365","author":"Dooley","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.pop.2020.08.003_bib31","first-page":"904","article-title":"Comparative efficacy and safety of tacrolimus, mycophenolate mofetil, azathioprine, and cyclophosphamide as maintenance therapy for lupus nephritis: a Bayesian network meta-analysis of randomized controlled trials","volume":"76","author":"Lee","year":"2016","journal-title":"Z\u00a0Rheumatol"},{"issue":"2","key":"10.1016\/j.pop.2020.08.003_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1681\/ASN.V72299","article-title":"Long-term outcome in systemic lupus erythematosus membranous glomerulonephritis. Lupus Nephritis Collaborative Study Group","volume":"7","author":"Sloan","year":"1996","journal-title":"J\u00a0Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.pop.2020.08.003_bib33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ki.2011.399","article-title":"Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion","volume":"81","author":"Sethi","year":"2012","journal-title":"Kidney Int"},{"issue":"3","key":"10.1016\/j.pop.2020.08.003_bib34","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2215\/CJN.06410613","article-title":"Update on membranoproliferative GN","volume":"9","author":"Masani","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.pop.2020.08.003_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nrneph.2014.217","article-title":"Histopathology of MPGN and C3 glomerulopathies","volume":"11","author":"Cook","year":"2015","journal-title":"Nat Rev Nephrol"},{"issue":"12","key":"10.1016\/j.pop.2020.08.003_bib36","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMra1108178","article-title":"Membranoproliferative glomerulonephritis--a new look at an old entity","volume":"366","author":"Sethi","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.pop.2020.08.003_bib37","first-page":"314","article-title":"The incidence of possible causes of membranoproliferative glomerulonephritis: a single-center experience","volume":"19","author":"Pavinic","year":"2015","journal-title":"Hippokratia"},{"key":"10.1016\/j.pop.2020.08.003_bib38","series-title":"Diagnostic criteria in autoimmune diseases","first-page":"503","article-title":"Membranoproliferative or mesangiocapillary glomerulonephritis","author":"Diaz","year":"2008"},{"issue":"3","key":"10.1016\/j.pop.2020.08.003_bib39","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.ki.5000084","article-title":"Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk","volume":"69","author":"Little","year":"2006","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.pop.2020.08.003_bib40","doi-asserted-by":"crossref","first-page":"c41","DOI":"10.1159\/000324652","article-title":"Treatment of hepatitis B virus-associated nephropathy","volume":"119","author":"Elewa","year":"2011","journal-title":"Nephron Clin Pract"},{"issue":"4","key":"10.1016\/j.pop.2020.08.003_bib41","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000442323","article-title":"Overview of the Pathogenesis of ANCA-Associated Vasculitis","volume":"1","author":"Xiao","year":"2016","journal-title":"Kidney Dis (Basel)"},{"issue":"2","key":"10.1016\/j.pop.2020.08.003_bib42","first-page":"65","article-title":"The initial predictors of death in 153 patients with ANCA-associated vasculitis in a single Korean centre","volume":"36 Suppl 111","author":"Mun","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"10.1016\/j.pop.2020.08.003_bib43","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/ki.2009.218","article-title":"The clinical course of ANCA small-vessel vasculitis on chronic dialysis","volume":"76","author":"Lionaki","year":"2009","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.pop.2020.08.003_bib44","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.2215\/CJN.02500317","article-title":"ANCA glomerulonephritis and vasculitis","volume":"12","author":"Jennette","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.pop.2020.08.003_bib45","article-title":"ANCA-associated vasculitis: core curriculum 2020","author":"Geetha","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.pop.2020.08.003_bib46","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.berh.2018.10.001","article-title":"Clinical features and structured clinical evaluation of vasculitis","volume":"32","author":"Ponte","year":"2018","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"10.1016\/j.pop.2020.08.003_bib47","doi-asserted-by":"crossref","first-page":"488","DOI":"10.7326\/0003-4819-116-6-488","article-title":"Wegener granulomatosis: an analysis of 158 patients","volume":"116","author":"Hoffman","year":"1992","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.pop.2020.08.003_bib48","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa0909169","article-title":"Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis","volume":"363","author":"Jones","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.pop.2020.08.003_bib49","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N\u00a0Engl J Med"}],"container-title":["Primary Care: Clinics in Office Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454320300579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0095454320300579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:43:36Z","timestamp":1758815016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0095454320300579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0095454320300579"],"URL":"https:\/\/doi.org\/10.1016\/j.pop.2020.08.003","relation":{},"ISSN":["0095-4543"],"issn-type":[{"value":"0095-4543","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nephritic Syndrome","name":"articletitle","label":"Article Title"},{"value":"Primary Care: Clinics in Office Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pop.2020.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}